Skip to main navigation Skip to search Skip to main content

Etiologic heterogeneity among non-hodgkin lymphoma subtypes: The interLymph non-hodgkin lymphoma subtypes project

  • Lindsay M. Morton
  • , Susan L. Slager
  • , James R. Cerhan
  • , Sophia S. Wang
  • , Claire M. Vajdic
  • , Christine F. Skibola
  • , Paige M. Bracci
  • , Silvia de Sanjosé
  • , Karin E. Smedby
  • , Brian C.H. Chiu
  • , Yawei Zhang
  • , Sam M. Mbulaiteye
  • , Alain Monnereau
  • , Jennifer J. Turner
  • , Jacqueline Clavel
  • , Hans Olov Adami
  • , Ellen T. Chang
  • , Bengt Glimelius
  • , Henrik Hjalgrim
  • , Mads Melbye
  • Paolo Crosignani, Simonetta di Lollo, Lucia Miligi, Oriana Nanni, Valerio Ramazzotti, Stefania Rodella, Adele Seniori Costantini, Emanuele Stagnaro, Rosario Tumino, Carla Vindigni, Paolo Vineis, Nikolaus Becker, Yolanda Benavente, Paolo Boffetta, Paul Brennan, Pierluigi Cocco, Lenka Foretova, Marc Maynadié, Alexandra Nieters, Anthony Staines, Joanne S. Colt, Wendy Cozen, Scott Davis, Anneclaire J. de Roos, Patricia Hartge, Nathaniel Rothman, Richard K. Severson, Elizabeth A. Holly, Timothy G. Call, Andrew L. Feldman, Thomas M. Habermann, Mark Liebow, Aaron Blair, Kenneth P. Cantor, Eleanor V. Kane, Tracy Lightfoot, Eve Roman, Alex Smith, Angela Brooks-Wilson, Joseph M. Connors, Randy D. Gascoyne, John J. Spinelli, Bruce K. Armstrong, Anne Kricker, Theodore R. Holford, Qing Lan, Tongzhang Zheng, Laurent Orsi, Luigino Dal Maso, Silvia Franceschi, Carlo La Vecchia, Eva Negri, Diego Serraino, Leslie Bernstein, Alexandra Levine, Jonathan W. Friedberg, Jennifer L. Kelly, Sonja I. Berndt, Brenda M. Birmann, Christina A. Clarke, Christopher R. Flowers, James M. Foran, Marshall E. Kadin, Ora Paltiel, Dennis D. Weisenburger, Martha S. Linet, Joshua N. Sampson
  • National Institutes of Health
  • Mayo Clinic Rochester, MN
  • City of Hope National Med Center
  • University of New South Wales
  • University of Alabama at Birmingham
  • University of California at San Francisco
  • Bellvitge Biomedical Research Institute
  • CIBER Epidemiología y Salud Pública (CIBERESP)
  • Karolinska Institutet
  • The University of Chicago
  • Yale University
  • Université Paris-Saclay
  • Centre Georges-François Leclerc
  • Douglass Hanly Moir Pathology
  • Macquarie University
  • Harvard University
  • Exponent, Inc.
  • Stanford University
  • Uppsala University
  • Statens Serum Institut
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • University of Florence
  • Centro Per Lo Studio E La Prevenzione Oncologica
  • IRCCS Istituto scientifico romagnolo per lo studio e la cura dei tumori - Meldola (FC)
  • IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
  • Agency for Health and Social Care
  • Istituto Nazionale Per la Ricerca Sul Cancro
  • ASP Ragusa
  • Azienda Ospedaliera Universitaria Senese
  • Imperial College London
  • German Cancer Research Center
  • International Agency for Research on Cancer
  • University of Cagliari
  • Masaryk Memorial Cancer Institute
  • Université de Bourgogne
  • University of Freiburg
  • Dublin City University
  • University of Southern California
  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • Drexel University
  • Wayne State University
  • University of York
  • Provincial Health Services Authority
  • Simon Fraser University
  • University of British Columbia
  • The University of Sydney
  • IRCCS Centro di Riferimento Oncologico - Aviano PN
  • IRCCS Istituto di ricerche farmacologiche Mario Negri - Milano, Bergamo, Ranica
  • University of Milan
  • University of Rochester
  • Cancer Prevention Institute of California
  • Emory University
  • Mayo Clinic in Jacksonville, Florida
  • Boston University
  • Roger Williams Hospital
  • Hadassah University Medical Centre

Research output: Contribution to journalArticlepeer-review

306 Scopus citations

Abstract

Background: Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous subtypes. Previously, study size has limited the ability to compare and contrast the risk factor profiles among these heterogeneous subtypes. Methods: We pooled individual-level data from 17 471 NHL cases and 23 096 controls in 20 case-control studies from the International Lymphoma Epidemiology Consortium (InterLymph). We estimated the associations, measured as odds ratios, between each of 11 NHL subtypes and self-reported medical history, family history of hematologic malignancy, lifestyle factors, and occupation. We then assessed the heterogeneity of associations by evaluating the variability (Q value) of the estimated odds ratios for a given exposure among subtypes. Finally, we organized the subtypes into a hierarchical tree to identify groups that had similar risk factor profiles. Statistical significance of tree partitions was estimated by permutation-based P values (PNODE). Results: Risks differed statistically significantly among NHL subtypes for medical history factors (autoimmune diseases, hepatitis C virus seropositivity, eczema, and blood transfusion), family history of leukemia and multiple myeloma, alcohol consumption, cigarette smoking, and certain occupations, whereas generally homogeneous risks among subtypes were observed for family history of NHL, recreational sun exposure, hay fever, allergy, and socioeconomic status. Overall, the greatest difference in risk factors occurred between T-cell and B-cell lymphomas (PNODE < 1.0 × 10-4), with increased risks generally restricted to T-cell lymphomas for eczema, T-cell-activating autoimmune diseases, family history of multiple myeloma, and occupation as a painter. We further observed substantial heterogeneity among B-cell lymphomas (PNODE < 1.0 × 10-4). Increased risks for B-cell-activating autoimmune disease and hepatitis C virus seropositivity and decreased risks for alcohol consumption and occupation as a teacher generally were restricted to marginal zone lymphoma, Burkitt/Burkitt-like lymphoma/leukemia, diffuse large B-cell lymphoma, and/or lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Conclusions: Using a novel approach to investigate etiologic heterogeneity among NHL subtypes, we identified risk factors that were common among subtypes as well as risk factors that appeared to be distinct among individual or a few subtypes, suggesting both subtype-specific and shared underlying mechanisms. Further research is needed to test putative mechanisms, investigate other risk factors (eg, other infections, environmental exposures, and diet), and evaluate potential joint effects with genetic susceptibility.

Original languageEnglish
Pages (from-to)130-144
Number of pages15
JournalJournal of the National Cancer Institute - Monographs
Issue number48
DOIs
StatePublished - Aug 2014

Fingerprint

Dive into the research topics of 'Etiologic heterogeneity among non-hodgkin lymphoma subtypes: The interLymph non-hodgkin lymphoma subtypes project'. Together they form a unique fingerprint.

Cite this